Physician

Andrew Ernest Fintel, D.O.

According to 2025 Medicare claims, Andrew Fintel, D.O. (NPI: 1578876843) practices hematology/oncology in the Roanoke, VA market, with the plurality of this provider's patient population coming from Roanoke City, VA. This provider's primary affiliated billing organization is ONCOLOGY AND HEMATOLOGY ASSOCIATES OF SOUTHWEST VIRGINIA, INC. (NPI: 1487621496; TIN: 541922084) and primary practice location at 24153-7474.

Fintel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 941 traditional Medicare patients, billed 263,033 HCPCS/CPT codes, and received $4,785,674 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,144 prescription claims across 365 beneficiaries totaling $3,656,343 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 88 claims. Open Payments data shows 32 records totaling $731. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $379,583 to $4,785,674. Similarly, Part D prescription costs have risen steadily, from $62,389 to $3,656,343. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	215	19,381	$379,583
2017	764	168,698	$2,615,029
2018	724	178,915	$2,768,293
2019	786	166,024	$2,605,563
2020	954	230,575	$3,631,435
2021	942	237,074	$4,002,058
2022	911	225,877	$3,499,240
2023	948	239,356	$3,917,193
2024	941	263,033	$4,785,674

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	41	109	$62,389
2017	211	1,060	$862,995
2018	230	1,343	$1,111,214
2019	241	1,446	$1,856,141
2020	325	1,899	$2,389,517
2021	354	2,221	$2,295,027
2022	349	1,963	$2,442,133
2023	344	1,774	$2,663,486
2024	365	2,144	$3,656,343

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	25	$1,471
2021	N/R	14	$1,093
2022	N/R	26	$426
2023	N/R	N/R	N/R
2024	N/R	88	$4,617

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	375	758	$89
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	426	549	$59
80053	Blood test, comprehensive group of blood chemicals	532	1,900	$10
36415	Insertion of needle into vein for collection of blood sample	531	1,214	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	686	2,556	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	52	1,449	$865,745
Revlimid	Lenalidomide	14	392	$256,593
Xtandi	Enzalutamide	18	540	$251,464
Tavalisse	Fostamatinib Disodium	14	420	$201,724
Jakafi	Ruxolitinib Phosphate	11	330	$185,803

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0656	Segmental pneumatic appliance for use with pneumatic compressor, trunk	Y	N/R	38	$1,793
E0657	Segmental pneumatic appliance for use with pneumatic compressor, chest	Y	N/R	38	$1,684
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	N/R	12	$1,141

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$731	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew Ernest Fintel, D.O.?

Tedicare shows public-source Medicare data for Andrew Ernest Fintel, D.O. (NPI 1578876843), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Ernest Fintel, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew Ernest Fintel, D.O.?

Andrew Ernest Fintel, D.O. is linked to ONCOLOGY AND HEMATOLOGY ASSOCIATES OF SOUTHWEST VIRGINIA, INC. (billing NPI 1487621496) in the available physician profile data.

Does Andrew Ernest Fintel, D.O. have Open Payments data?

Andrew Ernest Fintel, D.O. has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.